Hem › Myasthenia gravis › North Carolina
Kliniska studier för Myasthenia gravis i North Carolina
14 studier för Myasthenia gravis söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Velocity Clinical Research, Inc., Raleigh
- Atrium Health Wake Forest Baptist, Winston-Salem
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Fayetteville
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07647510ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, New Bern
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- UNC Hospitals - PARENT, Chapel Hill
- Atrium Health Wake Forest Baptist, Winston-Salem
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT06463587Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- The University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT06414954Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 30 juli 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Duke University School of Medicine, Durham
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of North Carolina Hospitals - Neurology Clinic, Chapel Hill
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 juni 2026 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Raleigh
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT07221838Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Chapel Hill
- Clinical Trial Site, Charlotte
- Clinical Trial Site, Durham
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 18 feb. 2026 · NCT04202341Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 2/3
Ålder 2 till 18 · Alla kön · Uppdaterad 18 feb. 2026 · NCT04833894The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Duke University, Durham
RekryterarFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 11 apr. 2025 · NCT05564936Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.